SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors react to a new strategic partnership with IREN to deploy large-scale AI infrastructure and reports of potential collaboration with SoftBank to develop localized server hardware in Japan. The community is actively discussing these expansion efforts alongside anticipation for upcoming earnings, with many focusing on the stock's role as the central anchor for global AI compute demand.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is currently the focus of intense investor attention ahead of upcoming earnings, with the community actively debating whether the company's turnaround efforts and shift toward unit-level profitability will successfully offset broader housing market headwinds. Discussion is dominated by speculative theories about potential catalysts, such as new service product rollouts, and a split sentiment between bulls who see a long-term growth story and bears who remain skeptical of continued financial losses.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant volatility ahead of earnings as investors weigh a massive revenue backlog against mounting debt and high capital expenditure. The community remains sharply divided, with bulls pointing to the company's strong hyperscaler partnerships as evidence of long-term dominance, while bears frequently cite concerns over unit economics and the potential for regulatory scrutiny regarding round-trip transactions.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is currently the focus of intense trading activity following the announcement of a multi-billion dollar AI infrastructure partnership with NVIDIA, which includes a warrant for potential equity investment at a fixed strike price. While the stock initially surged on the news, the community is actively debating the strength of the firm's underlying earnings performance versus the long-term potential of its pivot from bitcoin mining to AI cloud services.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme volatility ahead of its earnings report, with community sentiment deeply polarized between hopeful investors citing the CEO's personal stock purchases and frustrated shareholders reacting to recent executive departures and ongoing market underperformance. Discussion is heavily focused on potential partnership rumors with OpenAI and whether management can finally provide the catalyst needed to reverse the stock's persistent downward trend.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as shareholders weigh the impact of an active lawsuit against distribution partner NS Pharma, which the community views as a strategic effort to reclaim commercial rights before the upcoming FDA decision. Investors are closely monitoring the leadership transition at the FDA, hoping that a new CBER appointment will clear the regulatory path for Deramiocel's approval.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is capturing attention as market participants weigh long-term nuclear energy potential against heavy short interest and significant insider divestment from major stakeholders. While retail sentiment remains divided, community discourse heavily focuses on the companys regulatory status and its role in meeting the massive power demands of AI data centers.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is attracting significant attention as investors speculate on its potential to serve as a decentralized, sovereign cloud infrastructure that could rival Big Tech providers. The community is actively debating its long-term utility in hosting AI and enterprise applications, while many holders remain focused on accumulation and multi-year staking strategies despite recent price volatility.

A Paradise Acquisition Corp. is a blank check company. It engages in effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on November 9, 2022 and is headquartered in Hong Kong.

A Paradise Acquisition Corp. - Ordinary Shares - Class A

Investors are closely tracking the public market debut of Enhanced through its business combination with A Paradise Acquisition Corp. as community discussions center on the company's controversial focus on performance-enhanced sports and the potential scientific implications of its research initiatives.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is trending due to a major multi-year partnership with Nvidia to expand U.S. manufacturing of optical connectivity for AI infrastructure, including a $500 million equity investment. The community is actively discussing this news as a significant long-term catalyst for data center buildouts, while some investors remain cautious about the stock's valuation and volatility following its recent vertical price run.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update

Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update PR Newswire...

Wall Street Zen Downgrades Enliven Therapeutics (NASDAQ:ELVN) to Sell

Wall Street Zen downgraded shares of Enliven Therapeutics from a "hold" rating to a "sell" rating in a research report on Sunday...

Enliven Therapeutics (NASDAQ:ELVN) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Enliven Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...

Enliven Therapeutics (NASDAQ:ELVN) Hits New 1-Year High - Time to Buy?

Enliven Therapeutics (NASDAQ:ELVN) Reaches New 12-Month High - Should You Buy...

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Short Interest Down 26.3% in March

Enliven Therapeutics, Inc. (NASDAQ:ELVN - Get Free Report) was the recipient of a large drop in short interest in the month of March. As of March 31st, there was short interest totaling 6,053,456...

Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 4.2% - What's Next?

Enliven Therapeutics (NASDAQ:ELVN) Trading Down 4.2% - What's Next...

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating and five have given a buy rating to...

Enliven Therapeutics (NASDAQ:ELVN) Sets New 12-Month High - Should You Buy?

Enliven Therapeutics (NASDAQ:ELVN) Hits New 52-Week High - Here's What Happened...

Q1 EPS Estimate for Enliven Therapeutics Reduced by Analyst

Enliven Therapeutics, Inc. (NASDAQ:ELVN - Free Report) - HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for Enliven Therapeutics in a note issued to investors on Thursday...

Enliven Therapeutics (NASDAQ:ELVN) Given New $56.00 Price Target at HC Wainwright

HC Wainwright upped their price target on Enliven Therapeutics from $48.00 to $56.00 and gave the stock a "buy" rating in a research report on Thursday...

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.

ELVN
Enliven Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest ELVN News

ELVNEnliven Therapeutics Inc